Oruka Therapeutics, Inc.
ORKA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000907654
In the last 90 days, Oruka Therapeutics, Inc. insiders filed 0 open-market purchases and 15 sales; 255 institutions reported holding it in 13F filings for Q2 2026, worth $7.05B in total; Viking Global Investors is the only superinvestor holding it.
Q4 2021 vs. Q3 2021
How the institutions holding Oruka Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 19 | 21 | +2 |
| Shares | 1.53M | 1.12M | −407.7K (−26.7%) |
| Value | $4.53M | $2.41M | −$2.12M (−46.8%) |
New holders (5)
Institutions that held Oruka Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Acadian Asset Management LLC | 57,822 | $123.0K | 0.00% |
| Dimensional Fund Advisors LP | 42,498 | $91.0K | 0.00% |
| UBS Group AG | 7,584 | $16.0K | 0.00% |
| TD Waterhouse Canada Inc. | 1,300 | $2.89K | 0.00% |
| Tyler-Stone Wealth Management | 50 | $0 | 0.00% |
Sold out (3)
Institutions that held Oruka Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Gsa Capital Partners LLP | 441,945 | $1.31M |
| Alpine Global Management, LLC | 16,715 | $49.0K |
| Minerva Advisors LLC | 10,000 | $30.0K |